Alvotech, Advanz Pharma secure European approval for Gobivaz, Simponi biosimilar
Source: SeekingAlpha
2025-11-20 05:32:26 ET
More on Alvotech
- Alvotech (ALVO) Q3 2025 Earnings Call Transcript
- Alvotech 2025 Q3 - Results - Earnings Call Presentation
- Alvotech: Initiating With Hold Rating On FDA CRL AVT05 And Reduced EBITDA Guidance
- Alvotech GAAP EPS of $0.47 beats by $0.49
- Alvotech stock slides as FDA issues CRL for AVT05, company cuts EBITDA outlook
Read the full article on Seeking Alpha
For further details see:
Alvotech, Advanz Pharma secure European approval for Gobivaz, Simponi biosimilar
Alvotech
NASDAQ: ALVO
ALVO Trading
-0.74% G/L:
$3.345 Last:
91,623 Volume:
$3.31 Open:
ALVO Latest News
ALVO Stock Data
$1,569,389,520
107,654,085
N/A
30
N/A
Pharmaceuticals
Healthcare
LU
Luxembourg
